Body composition, physical activity, and quality of life in pediatric patients with inflammatory bowel disease on anti-TNF therapy-an observational follow-up study
- PMID: 36477672
- PMCID: PMC10017513
- DOI: 10.1038/s41430-022-01245-9
Body composition, physical activity, and quality of life in pediatric patients with inflammatory bowel disease on anti-TNF therapy-an observational follow-up study
Abstract
Background: Poor outcome of inflammatory bowel disease (IBD) is associated with malnutrition. Our aim was to compare body composition (BC) and physical activity (PA) between patients with IBD and healthy controls, and to assess the changes in BC, PA and health related quality of life (HRQoL) in children with IBD during anti-TNF therapy.
Methods: 32 children with IBD (21 with Crohn's disease (CD), (age: 15.2 ± 2.6 years, 9 male) and 11 with ulcerative colitis (UC), (age: 16.4 ± 2.2 years, 5 male) participated in this prospective, observational follow up study conducted at Semmelweis University, Hungary. As control population, 307 children (age: 14.3 ± 2.1) (mean ± SD) were included. We assessed BC via bioelectric impedance, PA and HRQoL by questionnaires at initiation of anti-TNF therapy, and at two and six months later. The general linear model and Friedman test were applied to track changes in each variable.
Results: During follow-up, the fat-free mass Z score of children with CD increased significantly (-0.3 vs 0.1, p = 0.04), while the BC of patients with UC did not change. PA of CD patients was lower at baseline compared to healthy controls (1.1 vs. 2.4), but by the end of the follow up the difference disappeared.
Conclusions: The fat-free mass as well as PA of CD patients increased during the first six months of anti-TNF treatment. As malnutrition and inactivity affects children with IBD during an important physical and mental developmental period, encouraging them to engage in more physical activity, and monitoring nutritional status should be an important goal in patient care.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Impact of malnutrition and sarcopenia on quality of life in patients with inflammatory bowel disease: A multicentre study.J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2663-2675. doi: 10.1002/jcsm.13341. Epub 2023 Oct 1. J Cachexia Sarcopenia Muscle. 2023. PMID: 37779327 Free PMC article.
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
-
Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.Dan Med J. 2014 Jan;61(1):B4778. Dan Med J. 2014. PMID: 24393595
-
Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study.Gastroenterol Hepatol. 2024 Jan;47(1):51-62. doi: 10.1016/j.gastrohep.2023.04.002. Epub 2023 Apr 14. Gastroenterol Hepatol. 2024. PMID: 37062500 English, Spanish.
-
Nutritional Status and Its Detection in Patients with Inflammatory Bowel Diseases.Nutrients. 2023 Apr 20;15(8):1991. doi: 10.3390/nu15081991. Nutrients. 2023. PMID: 37111210 Free PMC article. Review.
Cited by
-
Sarcopenia and frailty in inflammatory bowel disease: Emerging concepts and evidence.JGH Open. 2024 Jan 27;8(1):e13033. doi: 10.1002/jgh3.13033. eCollection 2024 Jan. JGH Open. 2024. PMID: 38283070 Free PMC article. Review.
-
Novel approach to assess sarcopenia in children with inflammatory bowel disease.Front Pediatr. 2024 Nov 19;12:1204639. doi: 10.3389/fped.2024.1204639. eCollection 2024. Front Pediatr. 2024. PMID: 39629099 Free PMC article.
-
Current Role of Monoclonal Antibody Therapy in Pediatric IBD: A Special Focus on Therapeutic Drug Monitoring and Treat-to-Target Strategies.Children (Basel). 2023 Mar 28;10(4):634. doi: 10.3390/children10040634. Children (Basel). 2023. PMID: 37189883 Free PMC article. Review.
-
Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease.Intest Res. 2025 Jul;23(3):254-289. doi: 10.5217/ir.2024.00185. Epub 2025 Apr 29. Intest Res. 2025. PMID: 40300749 Free PMC article. Review.
References
-
- Gatt K, Schembri J, Katsanos KH, Christodoulou D, Karmiris K, Kopylov U, et al. Inflammatory bowel disease [IBD] and physical activity: a study on the impact of diagnosis on the level of exercise amongst patients with IBD. J Crohns Colitis. 2019;13:686–92. doi: 10.1093/ecco-jcc/jjy214. - DOI - PubMed
-
- Mehta NM, Corkins MR, Lyman B, Malon A, Goda PS, Carney LN, et al. American society for parenteral and enteral nutrition board of directors. defining pediatric malnutrition: a paradigm shift toward etiology-related definitions. J Parenter Enter Nutr. 2013;37:460–81. doi: 10.1177/0148607113479972. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials